Secondary otalgia. Otalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Presence of an earache Age between 25 and 60 years Presence of active trigger points in any of the masseter, temporalis, medial and lateral pterygoid, upper trapezius, sternocleidomastoid, and sub-occipital muscles Presence of dysfunction in any of the cervical vertebrae
Exclusion criteria
Exclusion criteria: Diagnosis of primary otalgia External and internal ear infections Earwax Ear inflammation Limitation of range of motion of the temporomandibular joint with the presence of sound and sensitivity to touch in this joint Cervical discopathy Spinal canal stenosis in the cervical region Primary headaches Systemic diseases and positive vertebro-basilar test Head and neck malignancy Oral and mucosal lesions Dental injuries (dental and gum infections, abnormal alignment or placement of teeth when the mouth is closed) Sinusitis and upper airway infections diagnosed by an ear specialist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Participants were instructed to indicate their average pain intensity on a 0–10 numerical rating scale, where 0 represented “no pain” and 10 represented “the worst pain imaginable.”. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain frequency. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Number of days of pain in the past 10 days as reported by the patient.;Number of trigger points. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Presence of referred pain and a jump sign on manual examination.;Cervical range of motion. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Goniometry.;Mandibular depression range. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Number of sticks placed in the mouth.;Quality of life. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: SF-36 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Science